SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-090306
Filing Date
2024-08-16
Accepted
2024-08-16 07:03:07
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-08-16

Document Format Files

Seq Description Document Type Size
1 ARS tm2421739d1_ars.pdf ARS 806788
  Complete submission text file 0001104659-24-090306.txt   1112915
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36641 | Film No.: 241214113
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)